Cargando…
Novel PF74-like small molecules targeting the HIV-1 capsid protein: Balance of potency and metabolic stability
Of all known small molecules targeting human immunodeficiency virus (HIV) capsid protein (CA), PF74 represents by far the best characterized chemotype, due to its ability to confer antiviral phenotypes in both early and late phases of viral replication. However, the prohibitively low metabolic stabi...
Autores principales: | Wang, Lei, Casey, Mary C., Vernekar, Sanjeev Kumar V., Sahani, Rajkumar Lalji, Kirby, Karen A., Du, Haijuan, Zhang, Huanchun, Tedbury, Philip R., Xie, Jiashu, Sarafianos, Stefan G., Wang, Zhengqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982424/ https://www.ncbi.nlm.nih.gov/pubmed/33777683 http://dx.doi.org/10.1016/j.apsb.2020.07.016 |
Ejemplares similares
-
Design, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74
por: Sahani, Rajkumar Lalji, et al.
Publicado: (2021) -
Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules
por: Vernekar, Sanjeev Kumar V., et al.
Publicado: (2020) -
Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches
por: Senaweera, Sameera, et al.
Publicado: (2021) -
HIV Capsid Inhibitors Beyond PF74
por: McArthur, Carole, et al.
Publicado: (2019) -
Rotten to the core: antivirals targeting the HIV-1 capsid core
por: McFadden, William M., et al.
Publicado: (2021)